Martha Glenn, MD, is a medical oncologist and an associate professor of internal medicine at the University of Utah School of Medicine. She treats patients with blood-related cancers such as leukemia and lymphomas. She is also participating in leukemia research and clinical trials for lymphoma at Huntsman Cancer Institute. The clinical trials are testing methods for treating low-grade lymphomas. They are called radio-labeled monoclonal treatment, and they involve tumor-specific radiation therapy. Tumor-specific treatment is more precise than some other forms of radiation therapy because it is applied directly to the cancer.

Glenn completed her medical training at Columbia University in New York City and a fellowship in hematology/oncology at Memorial Sloan-Kettering Cancer Center, also in New York City.